title: Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?
abstract: Alzheimer's disease is the most common form of dementia in the elderly. Currently, there is no established standard treatment for this disease; therefore, the treatment of Alzheimer's disease will be a major challenge for physicians in the next decade in order to ameliorate quality of life of patients and reduce the costs for the communities.
authors.affiliation: Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Francesco
authors.initials: F
authors.lastname: Mattace-Raso
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008559:Memantine / Q000008:administration & dosage*; D018697:Nootropic Agents / Q000008:administration & dosage*
chemical_list: D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D008559:Memantine